Takeda Y, et al. (2017) A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy. Cell Rep 19(9):1874-1887
Paste the following link
Lists
This AllelePublication isn't in any lists. Upload a list.